Back
Janux Therapeutics Stock Price Chart
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!
Sell
36
JANX
Janux Therapeutics
Last Price:
53.79
Seasonality Move:
-0.53%
7 Day Trial
ALL ACCESS PASS
$
7
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade- The current trend is moderately bullish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.
Janux Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 54.81 | Sell |
| 20-day SMA: | 52.99 | Buy |
| 50-day SMA: | 48.92 | Buy |
| 200-day SMA: | 41.64 | Buy |
| 8-day EMA: | 54.33 | Sell |
| 20-day EMA: | 52.77 | Buy |
| 50-day EMA: | 49.64 | Buy |
| 200-day EMA: | 40.44 | Buy |
Janux Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.91 | Buy |
| Relative Strength Index (14 RSI): | 57.67 | Buy |
| Chaikin Money Flow: | -619876 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (47.9 - 55.08) | Buy |
| Bollinger Bands (100): | (40.26 - 50.38) | Buy |
Janux Therapeutics Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Janux Therapeutics Stock
Is Janux Therapeutics Stock a Buy?
- Janux Therapeutics share price is 53.92 while JANX 8-day simple moving average is 54.81, which is a Sell signal.
- The stock price of JANX is 53.92 while Janux Therapeutics 20-day SMA is 52.99, which makes it a Buy.
- Janux Therapeutics 50-day simple moving average is 48.92 while JANX share price is 53.92, making it a Buy technically.
- JANX stock price is 53.92 and Janux Therapeutics 200-day simple moving average is 41.64, creating a Buy signal.
JANX Technical Analysis vs Fundamental Analysis
Sell
36
Janux Therapeutics (JANX)
is a Sell
Is Janux Therapeutics a Buy or a Sell?
-
Janux Therapeutics stock is rated a Sell
The current Janux Therapeutics [JANX] share price is $53.92. The Score for JANX is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
Janux Therapeutics Stock Info
Market Cap:
2.83B
Price in USD:
53.92
Share Volume:
844.96K
Janux Therapeutics 52-Week Range
52-Week High:
65.60
52-Week Low:
5.65
Sell
36
Janux Therapeutics (JANX)
is a Sell
Janux Therapeutics Share Price Forecast
-
What is the Janux Therapeutics stock price today?
The Janux Therapeutics stock price is 53.92 USD today. -
Will JANX stock go up or go down?
Janux Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Janux Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Janux Therapeutics is overvalued.
Is Janux Therapeutics Stock a Buy?
- Janux Therapeutics share price is 53.92 while JANX 8-day exponential moving average is 54.33, which is a Sell signal.
- The stock price of JANX is 53.92 while Janux Therapeutics 20-day EMA is 52.77, which makes it a Buy.
- Janux Therapeutics 50-day exponential moving average is 49.64 while JANX share price is 53.92, making it a Buy technically.
- JANX stock price is 53.92 and Janux Therapeutics 200-day simple moving average is 40.44, creating a Buy signal.
Fundamental Analysis of Janux Therapeutics
Is Janux Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and a decrease next year of $0.37 per share.
Technical Analysis of Janux Therapeutics
Should I short Janux Therapeutics stock?
- JANX Moving Average Covergence Divergence (MACD) indicator is 1.91, suggesting Janux Therapeutics is a Buy
- Janux Therapeutics Relative Strength Index (RSI) is 57.67, which suggest Janux Therapeutics is overbought
- The Bollinger Bands (25) for Janux Therapeutics is (47.9 - 55.08), which suggest Janux Therapeutics is a Buy
- The Bollinger Bands (100) for Janux Therapeutics is (40.26 - 50.38), which suggest Janux Therapeutics is a Buy
* Janux Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.